200 related articles for article (PubMed ID: 34217325)
1. Multi-responsive nanofibers composite gel for local drug delivery to inhibit recurrence of glioma after operation.
Zhu Y; Jia J; Zhao G; Huang X; Wang L; Zhang Y; Zhang L; Konduru N; Xie J; Yu R; Liu H
J Nanobiotechnology; 2021 Jul; 19(1):198. PubMed ID: 34217325
[TBL] [Abstract][Full Text] [Related]
2. Injectable postoperative enzyme-responsive hydrogels for reversing temozolomide resistance and reducing local recurrence after glioma operation.
Zhao Z; Shen J; Zhang L; Wang L; Xu H; Han Y; Jia J; Lu Y; Yu R; Liu H
Biomater Sci; 2020 Sep; 8(19):5306-5316. PubMed ID: 32573615
[TBL] [Abstract][Full Text] [Related]
3. Dual-sensitive drug-loaded hydrogel system for local inhibition of post-surgical glioma recurrence.
Chen S; Qiu Q; Wang D; She D; Yin B; Gu G; Chai M; Heo DN; He H; Wang J
J Control Release; 2022 Sep; 349():565-579. PubMed ID: 35835399
[TBL] [Abstract][Full Text] [Related]
4. The use of TMZ embedded hydrogels for the treatment of orthotopic human glioma xenografts.
Adhikari B; Li J; Brandel MG; Futalan D; Akers J; Deming T; Chen CC; Carter BS
J Clin Neurosci; 2017 Nov; 45():288-292. PubMed ID: 28867360
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of fibrin glue containing temozolomide against malignant glioma.
Anai S; Hide T; Takezaki T; Kuroda J; Shinojima N; Makino K; Nakamura H; Yano S; Kuratsu J
Cancer Sci; 2014 May; 105(5):583-91. PubMed ID: 24673719
[TBL] [Abstract][Full Text] [Related]
6. Local delivery of slow-releasing temozolomide microspheres inhibits intracranial xenograft glioma growth.
Dong J; Zhou G; Tang D; Chen Y; Cui B; Dai X; Zhang J; Lan Q; Huang Q
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2079-84. PubMed ID: 22825126
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
Lin CJ; Lee CC; Shih YL; Lin TY; Wang SH; Lin YF; Shih CM
Free Radic Biol Med; 2012 Jan; 52(2):377-91. PubMed ID: 22094224
[TBL] [Abstract][Full Text] [Related]
8. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
[TBL] [Abstract][Full Text] [Related]
9. Injectable Drug-Conjugated DNA Hydrogel for Local Chemotherapy to Prevent Tumor Recurrence.
Zhang J; Guo Y; Pan G; Wang P; Li Y; Zhu X; Zhang C
ACS Appl Mater Interfaces; 2020 May; 12(19):21441-21449. PubMed ID: 32314901
[TBL] [Abstract][Full Text] [Related]
10. Intratumoral injection of thermogelling and sustained-release carboplatin-loaded hydrogel simplifies the administration and remains the synergistic effect with radiotherapy for mice gliomas.
Liang HT; Lai XS; Wei MF; Lu SH; Wen WF; Kuo SH; Chen CM; Tseng WI; Lin FH
Biomaterials; 2018 Jan; 151():38-52. PubMed ID: 29059540
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
Sun S; Lee D; Ho AS; Pu JK; Zhang XQ; Lee NP; Day PJ; Lui WM; Fung CF; Leung GK
Neuro Oncol; 2013 May; 15(5):562-77. PubMed ID: 23444257
[TBL] [Abstract][Full Text] [Related]
12. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy.
Mao J; Meng X; Zhao C; Yang Y; Liu G
Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
[TBL] [Abstract][Full Text] [Related]
14. Codelivery of paclitaxel and temozolomide through a photopolymerizable hydrogel prevents glioblastoma recurrence after surgical resection.
Zhao M; Bozzato E; Joudiou N; Ghiassinejad S; Danhier F; Gallez B; Préat V
J Control Release; 2019 Sep; 309():72-81. PubMed ID: 31306678
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide-loaded photopolymerizable PEG-DMA-based hydrogel for the treatment of glioblastoma.
Fourniols T; Randolph LD; Staub A; Vanvarenberg K; Leprince JG; Préat V; des Rieux A; Danhier F
J Control Release; 2015 Jul; 210():95-104. PubMed ID: 25982679
[TBL] [Abstract][Full Text] [Related]
16. Thermoresponsive nanocomposite gel for local drug delivery to suppress the growth of glioma by inducing autophagy.
Ding L; Wang Q; Shen M; Sun Y; Zhang X; Huang C; Chen J; Li R; Duan Y
Autophagy; 2017 Jul; 13(7):1176-1190. PubMed ID: 28594260
[TBL] [Abstract][Full Text] [Related]
17. ATRX/EZH2 complex epigenetically regulates FADD/PARP1 axis, contributing to TMZ resistance in glioma.
Han B; Meng X; Wu P; Li Z; Li S; Zhang Y; Zha C; Ye Q; Jiang C; Cai J; Jiang T
Theranostics; 2020; 10(7):3351-3365. PubMed ID: 32194873
[No Abstract] [Full Text] [Related]
18. Intranasal Delivery of Immunotherapeutic Nanoformulations for Treatment of Glioma Through in situ Activation of Immune Response.
Yin P; Li H; Ke C; Cao G; Xin X; Hu J; Cai X; Li L; Liu X; Du B
Int J Nanomedicine; 2020; 15():1499-1515. PubMed ID: 32189965
[TBL] [Abstract][Full Text] [Related]
19. Local Delivery of Minocycline and Vorinostat Targets the Tumor Microenvironment to Inhibit the Recurrence of Glioma.
Zhao G; Jia J; Wang L; Zhang Y; Yang H; Lu Y; Yu R; Liu H; Zhu Y
Onco Targets Ther; 2020; 13():11397-11409. PubMed ID: 33192073
[TBL] [Abstract][Full Text] [Related]
20. A Potential Nanofiber Membrane Device for Filling Surgical Residual Cavity to Prevent Glioma Recurrence and Improve Local Neural Tissue Reconstruction.
Huang D; Lin C; Wen X; Gu S; Zhao P
PLoS One; 2016; 11(8):e0161435. PubMed ID: 27548322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
